Jeffrey A. Nemeth

3.4k total citations
45 papers, 2.5k citations indexed

About

Jeffrey A. Nemeth is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jeffrey A. Nemeth has authored 45 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jeffrey A. Nemeth's work include Prostate Cancer Treatment and Research (13 papers), Cell Adhesion Molecules Research (12 papers) and Cytokine Signaling Pathways and Interactions (10 papers). Jeffrey A. Nemeth is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Cell Adhesion Molecules Research (12 papers) and Cytokine Signaling Pathways and Interactions (10 papers). Jeffrey A. Nemeth collaborates with scholars based in United States, Austria and Singapore. Jeffrey A. Nemeth's co-authors include Michael L. Cher, Mohit Trikha, Mohamed H. Zaki, Charles L. Goolsby, Chung Lee, Lanxi Song, Eric B. Haura, Bhupendra Rawal, David J. Grignon and Ubirajara Barroso and has published in prestigious journals such as Blood, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Jeffrey A. Nemeth

45 papers receiving 2.5k citations

Peers

Jeffrey A. Nemeth

ONCOL

PRM

IMMUN

Marya F. McCarty United States

Mohit Trikha United States

Emilia Fransvea Italy

Koh‐ichi Nakashiro Japan

Laetitia Devy Belgium

Michio Sowa Japan

Angela Garofalo Italy

Rachel Tsan United States

M Imamura Japan

Serk In Park United States

Marya F. McCarty United States

Jeffrey A. Nemeth

1.1k ×0.9

ONCOL

2.0k ×1.9

869 ×1.3

285 ×0.5

PRM

436 ×0.9

IMMUN

Citations per year, relative to Jeffrey A. Nemeth Jeffrey A. Nemeth (= 1×) peers Marya F. McCarty

Countries citing papers authored by Jeffrey A. Nemeth

Since Specialization

Citations

This map shows the geographic impact of Jeffrey A. Nemeth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey A. Nemeth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey A. Nemeth more than expected).

Fields of papers citing papers by Jeffrey A. Nemeth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey A. Nemeth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey A. Nemeth. The network helps show where Jeffrey A. Nemeth may publish in the future.

Co-authorship network of co-authors of Jeffrey A. Nemeth

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey A. Nemeth. A scholar is included among the top collaborators of Jeffrey A. Nemeth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey A. Nemeth. Jeffrey A. Nemeth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Serk In, Jinhui Liao, Janice E. Berry, et al.. (2012). Cyclophosphamide Creates a Receptive Microenvironment for Prostate Cancer Skeletal Metastasis. Cancer Research. 72(10). 2522–2532. 58 indexed citations

Guo, Yuqi, Jeffrey A. Nemeth, Conan J O O’Brien, et al.. (2010). Effects of Siltuximab on the IL-6–Induced Signaling Pathway in Ovarian Cancer. Clinical Cancer Research. 16(23). 5759–5769. 87 indexed citations

Puhr, Martin, Frédéric R. Santer, Hannes Neuwirt, et al.. (2009). Down-regulation of Suppressor of Cytokine Signaling-3 Causes Prostate Cancer Cell Death through Activation of the Extrinsic and Intrinsic Apoptosis Pathways. Cancer Research. 69(18). 7375–7384. 77 indexed citations

Millar, Hillary J., Jeffrey A. Nemeth, Francis L. McCabe, Bill Pikounis, & Eric Wickstrom. (2008). Circulating Human Interleukin-8 as an Indicator of Cancer Progression in a Nude Rat Orthotopic Human Non–Small Cell Lung Carcinoma Model. Cancer Epidemiology Biomarkers & Prevention. 17(8). 2180–2187. 20 indexed citations

Voorhees, Peter M., Qing Chen, Deborah J. Kuhn, et al.. (2007). Inhibition of Interleukin-6 Signaling with CNTO 328 Enhances the Activity of Bortezomib in Preclinical Models of Multiple Myeloma. Clinical Cancer Research. 13(21). 6469–6478. 93 indexed citations

Steiner, Hannes, Ilaria T. Cavarretta, Patrizia Moser, et al.. (2006). Regulation of growth of prostate cancer cells selected in the presence of interleukin-6 by the anti-interleukin-6 antibody CNTO 328. The Prostate. 66(16). 1744–1752. 36 indexed citations

Miyagi, Tohru, et al.. (2006). Effect of a pan anti-human alpha-v integrin antibody, CNTO95, on the adhesion, migration and growth of prostate cancer cells in culture and in a mouse model of human prostate cancer bone metastasis. Cancer Research. 66. 276–276. 1 indexed citations

Cavarretta, Ilaria T., Hannes Neuwirt, Gerold Untergasser, et al.. (2006). The antiapoptotic effect of IL-6 autocrine loop in a cellular model of advanced prostate cancer is mediated by Mcl-1. Oncogene. 26(20). 2822–2832. 94 indexed citations

Kim, Louis J., et al.. (2003). Scalp burns from halo pins following magnetic resonance imaging. Journal of neurosurgery. 99(1). 186–186. 9 indexed citations

10.

Nie, Daotai, Jeffrey A. Nemeth, Yan Qiao, et al.. (2003). Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase. Clinical & Experimental Metastasis. 20(7). 657–663. 53 indexed citations

11.

Trikha, Mohit, József Tı́már, Alex Zacharek, et al.. (2002). Role for β3 integrins in human melanoma growth and survival. International Journal of Cancer. 101(2). 156–167. 49 indexed citations

12.

Nemeth, Jeffrey A.. (2002). Matrix Metalloproteinase Activity, Bone Matrix Turnover, and Tumor Cell Proliferation in Prostate Cancer Bone Metastasis. JNCI Journal of the National Cancer Institute. 94(1). 17–25. 172 indexed citations

13.

Bianco, Fernando J., et al.. (2001). Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer. The Prostate. 49(4). 235–242. 28 indexed citations

14.

Nemeth, Jeffrey A., et al.. (2000). Persistence of human vascular endothelium in experimental human prostate cancer bone tumors. Clinical & Experimental Metastasis. 18(3). 231–237. 14 indexed citations

15.

Ilio, Kenneth Y., et al.. (1998). The Primary Culture of Rat Prostate Basal Cells. Journal of Andrology. 19(6). 718–724. 18 indexed citations

16.

Nemeth, Jeffrey A., et al.. (1997). Prostatic ductal system in rats: Tissue-specific expression and regional variation in stromal distribution of transforming growth factor-β1. The Prostate. 33(1). 64–71. 51 indexed citations

17.

Nemeth, Jeffrey A., et al.. (1996). TIMP-2 Growth-Stimulatory Activity: A Concentration- and Cell Type-Specific Response in the Presence of Insulin. Experimental Cell Research. 224(1). 110–115. 68 indexed citations

18.

Nemeth, Jeffrey A. & Chung Lee. (1996). Prostatic ductal system in rats: Regional variation in stromal organization. The Prostate. 28(2). 124–128. 80 indexed citations

19.

Nemeth, Jeffrey A. & Charles L. Goolsby. (1993). TIMP-2, a Growth-Stimulatory Protein from SV40-Transformed Human Fibroblasts. Experimental Cell Research. 207(2). 376–382. 62 indexed citations

20.

Goolsby, Charles L., Marianne Steiner, & Jeffrey A. Nemeth. (1991). Viral and cellular oncogene expression during progressive malignant transformation of SV40 transformed human fibroblasts. Cytometry. 12(8). 748–756. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact